Clinical presentation and management of an Aruban rattlesnake bite in the Netherlands

Autor: Jan Meulenbelt, Marieke A. Dijkman, Dorien E M Damhuis, Irma de Vries
Rok vydání: 2016
Předmět:
0301 basic medicine
Male
Time Factors
Antivenom
venomous exotic snakebite
Snake Bites
Case Reports
Toxicology
chemistry.chemical_compound
0302 clinical medicine
030202 anesthesiology
Medicine
Snake antivenom
Creatine Kinase
Blood coagulation test
Netherlands
biology
Antivenins
Disease Management
Crotalus
General Medicine
Middle Aged
haematotoxicity
Hospitalization
Treatment Outcome
Anesthesia
Blood Coagulation Tests
medicine.medical_specialty
Creatine
complex mixtures
03 medical and health sciences
national serum depot
Journal Article
Animals
Humans
Envenomation
Blood Coagulation
Dose-Response Relationship
Drug
business.industry
Platelet Count
Fibrinogen
biology.organism_classification
medicine.disease
Snake bites
Surgery
030104 developmental biology
chemistry
biology.protein
Creatine kinase
business
Zdroj: Clinical Toxicology, 54(5), 447. Informa Healthcare
ISSN: 1556-9519
1556-3650
Popis: Bites by Aruban Rattlesnake (Crotalus durissus unicolor) are rare and not known to induce severe envenomations. Here, we present a case of a 57 year-old man bitten by his pet Aruban Rattlesnake (Crotalus durissus unicolor). He was admitted to hospital within 15 min. Three and a half hours later his fibrinogen concentration decreased to 0.6 g/L (normal: 2.0-4.0). Nine hours post-bite, he was treated with polyvalent snake antivenom covering Crotalus durissus. Three hours later his fibrinogen became undetectable while at that time clotting times were prolonged (PT 38.7 s (normal: 12.5-14.5) and aPTT 40 s (normal: 25-35)). His platelet count remained within normal limits. Creatine kinase (CK) concentrations reached a maximum of 1868 U/L (normal
Databáze: OpenAIRE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje